Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Pharmacogenetic Testing and Application: 2024 Updated Guidelines by the Korean Society for Laboratory Medicine. | Ann Lab Med | 2025 | 39681357 | PubTator, text mining | PubMed |
| Utilization and associated factors of TPMT testing among Australian adults receiving thiopurines: A national retrospective data-linkage study. | Pharmacotherapy | 2025 | 39587965 | PubTator, text mining | PubMed |
| Contemporary and prospective use of azathioprine (AZA) in viral, rheumatic, and dermatological disorders: a review of pharmacogenomic and nanotechnology applications. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39495265 | PubTator, text mining | PubMed |
| Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice. | J Clin Oncol | 2025 | 39481076 | PubTator, text mining | PubMed |
| Budget impact analysis of TPMT and NUDT15 pharmacogenomic testing for 6-mercaptopurine in pediatric acute lymphoblastic leukemia patients. | Pharmacogenet Genomics | 2025 | 39470342 | PubTator, text mining | PubMed |
| Thiopurine S‑methyltransferase- and indolethylamine N‑methyltransferase-mediated formation of methylated tellurium compounds from tellurite. | Arch Toxicol | 2025 | 39417876 | PubTator, text mining | PubMed |
| Implementation of a pharmacist-guided pharmacogenomics dosing service at a rural NCI-designated comprehensive cancer center. | J Oncol Pharm Pract | 2025 | 39228222 | PubTator, text mining | PubMed |
| Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease. | Clin Gastroenterol Hepatol | 2025 | 39181428 | PubTator, text mining | PubMed |
| Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2025 | 39011784 | PubTator, text mining | PubMed |
| Association of intestinal anti-inflammatory drug target genes with psychiatric Disorders: A Mendelian randomization study. | J Adv Res | 2025 | 38735387 | PubTator, text mining | PubMed |
| AIH Therapy: Beyond First‑Line. | Curr Hepatol Rep | 2024 | 41585412 | PubTator, text mining | PubMed |
| TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience. | Pharmacogenomics | 2024 | 39957149 | PubTator, text mining | PubMed |
| Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023. | Front Pharmacol | 2024 | 39830351 | PubTator, text mining | PubMed |
| A Rapid and Reliable Absorbance Assay to Identify Drug-Drug Interactions with Thiopurine Drugs. | Metabolites | 2024 | 39728496 | PubTator, text mining | PubMed |
| Efficacy and safety of azathioprine in patients with Cronkhite-Canada syndrome: a case series from Peking Union Medical College Hospital. | BMC Pharmacol Toxicol | 2024 | 39696474 | PubTator, text mining | PubMed |
| Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine. | Front Pharmacol | 2024 | 39691389 | PubTator, text mining | PubMed |
| Genetic association analysis and frequency of NUDT15*3 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease in a large Dutch cohort. | Pharmacogenomics J | 2024 | 39580429 | PubTator, text mining | PubMed |
| SSEmb: A joint embedding of protein sequence and structure enables robust variant effect predictions. | Nat Commun | 2024 | 39511177 | PubTator, text mining | PubMed |
| Genetic profiling of NUDT15 in the Slovenian population. | Pharmacogenomics | 2024 | 39453028 | PubTator, text mining | PubMed |
| Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients. | Pharmacogenomics | 2024 | 39382000 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=8